Kraig Biocraft Laboratories Posts Recording of CEO's Shareholder Conference Call Regarding Spider Silk Technology Breakthrough
October 12 2010 - 6:05AM
Marketwired
Kraig Biocraft Laboratories, Inc. (PINKSHEETS: KBLB) announces that
a recorded copy of the Friday, October 8, 2010 shareholders
teleconference call is now available on the Company's website.
In that call, the Company's CEO, Kim Thompson reviewed: the
recent development of recombinant spider silk technology; the
Company's intellectual property and commercialization rights to
this technology; the research and development pipeline; as well as
revealing his vision for the future and growth of this
biotechnology company.
Interested parties are invited to listen to the teleconference
call with Kim Thompson, the Company's CEO and founder. The
conference call is available on the Company's website homepage at
http://www.KraigLabs.com.
Additionally, interested parties are encouraged by the Company
to use the following link,
http://www.youtube.com/watch?v=GnUupDb2Mvo, to view a video of the
public press conference announcement concerning the recent
scientific breakthrough.
Additional information is available on Kraig Biocraft
Laboratories (KBLB) web site: http://www.KraigLabs.com.
Statements in this press release about the company's future and
expectations other than historical facts are "forward-looking
statements." These statements are made on the basis of management's
current views and assumptions. As a result, there can be no
assurance that management's expectations will necessarily come to
pass. These forward-looking statements generally can be identified
by phrases such as "believes," "plans," "expects," "anticipates,"
"foresees," "hopes," "develops," "researching," "research,"
"potential," "could" or other words or phrases of similar import.
Similarly, statements in this release that describe the Company's
business strategy, outlook, objectives, plans, intentions or goals
should all be considered forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements. Management cautions that
its ability to further its research, and create commercially-viable
products may be affected by the competitive environment, the
Company's financial condition and its ability to raise sufficient
capital to meet the financial obligations of its business plan and
to fund its continuing operations.
Contact: Ben Hansel (720) 288-8495 Email Contact
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From May 2024 to Jun 2024
Kraig Biocraft Laborator... (QB) (USOTC:KBLB)
Historical Stock Chart
From Jun 2023 to Jun 2024